4 Midcap Low Debt and Fast Revenue Growth Stocks to Watch for Future Multibagger Potential: Coforge, Apar Industries, Sona BLW and Ajanta Pharma
- October 30, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Coforge Rs 1,962. Apar Industries Rs 15,846. Sona BLW Rs 873.60. Ajanta Pharma Rs 3,459.70. Market caps from Rs 43,549 crore to Rs 88,801 crore. Data as of 29 Oct 2026.
Quick Answer
Coforge, Apar Industries, Sona BLW and Ajanta Pharma are the 4 picks in this low debt and fast revenue growth stocks watchlist, with market caps between Rs 43,549 crore and Rs 88,801 crore. Coforge stands out for the largest market cap at Rs 88,801 crore, while Apar Industries offers the fastest profit growth, 39.67% a year since FY22. PE ratios run from 38.37 to 82.90, so compare each one with its industry PE before investing. All figures are as of 29 October 2026.
Low debt and fast revenue growth stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Coforge, Apar Industries, Sona BLW and Ajanta Pharma meet that test, with market caps from Rs 43,549 crore to Rs 88,801 crore and Coforge offering the largest market cap at Rs 88,801 crore. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a debt to equity ratio below 0.3 and FY26 revenue growth of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a debt to equity ratio below 0.3 and FY26 revenue growth of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening low debt and fast revenue growth stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 29 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Low Debt and Fast Revenue Growth Stocks and Why Do They Attract Multibagger Interest?
Low debt and fast revenue growth stocks are shares of mid sized companies that carry very little debt and still grew sales by fifteen per cent or more in FY26, which shows that growth is coming from the business and not from borrowing. The four here cover IT services, conductors, auto components and pharmaceuticals.
Growth that is not funded by heavy borrowing is safer, because the company does not have to pay large interest bills, and rising profit shows that the extra sales are paying off. Within low debt and fast revenue growth stocks, the four companies show rising profit. For low debt and fast revenue growth stocks, both FY26 and the latest quarter showed growth. Whichever way you read low debt and fast revenue growth stocks, the common thread is rising profit backed by complete financial data. For low debt and fast revenue growth stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of low debt and fast revenue growth stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for low debt and fast revenue growth stocks before you decide.
Low Debt and Fast Revenue Growth Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 29 October 2026. Ajanta Pharma combines the lowest PE of the group, 38.37, with the highest return on equity, 23.33%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Coforge | 1,962 | 88,801 | 46.24 | 17.66 | 16.31% | 0.08 | 1,008.10 to 2,021.20 |
| Apar Industries | 15,846 | 80,856 | 68.43 | 46.39 | 18.11% | 0.18 | 6,801.00 to 19,265.00 |
| Sona BLW Precision Forgings | 873.60 | 56,870 | 82.90 | 37.33 | 10.70% | 0.07 | 434.40 to 879.45 |
| Ajanta Pharma | 3,459.70 | 43,549 | 38.37 | 36.35 | 23.33% | 0.06 | 2,380.20 to 3,796.00 |
Coforge: 23.72% Profit CAGR Since FY22
Coforge is an IT services company serving clients in travel, banking, insurance and other industries. It reported FY26 revenue of Rs 16,475.90 crore, up 34.63% year on year, and net profit of Rs 1,674.50 crore, up 73.79%. Net profit has compounded at 23.72% a year since FY22, while revenue has grown 26.26% a year. Operating margin was 17.40% in FY26. The debt-to-equity ratio is 0.08, which keeps interest costs low.
In the June 2026 quarter, revenue rose 49.19% to Rs 5,554.50 crore and net profit grew 49.19% to Rs 531.70 crore. The share price has gained 73.24% over five years and 10.25% over the past year. The stock trades at a PE of 46.24 against an industry PE of 17.66, with a return on equity of 16.31%.
Apar Industries: 39.67% Profit CAGR Since FY22
Apar Industries makes conductors, specialty cables and transformer oils, and earns a large share of revenue from exports. It reported FY26 revenue of Rs 22,966.89 crore, up 22.95% year on year, and net profit of Rs 976.93 crore, up 18.95%. Net profit has compounded at 39.67% a year since FY22, while revenue has grown 25.19% a year. Operating margin was 8.49% in FY26. The debt-to-equity ratio is 0.18.
The stock trades at a PE of 68.43 against an industry PE of 46.39, with a return on equity of 18.11%. In the June 2026 quarter, revenue rose 29.16% to Rs 6,624.71 crore and net profit grew 77.80% to Rs 467.45 crore. The share price has gained 2287.98% over five years and 102.57% over the past year. Domestic institutions raised their holding from 22.64% in September 2025 to 24.88% in August 2026.
Sona BLW: Revenue Up 24.19% in FY26
Sona BLW makes differential gears, motors and drive systems for electric and conventional vehicles for customers around the world. It reported FY26 revenue of Rs 4,572.11 crore, up 24.19% year on year, and net profit of Rs 629.19 crore, up 4.92%. Net profit has compounded at 14.86% a year since FY22, while revenue has grown 20.75% a year. Operating margin was 25.91% in FY26. The debt-to-equity ratio is 0.07, which keeps interest costs low.
In the June 2026 quarter, revenue rose 49.27% to Rs 1,336.07 crore and net profit grew 46.67% to Rs 178.51 crore. The share price is up 70.74% over the past year. Domestic institutions raised their holding from 34.59% in June 2025 to 41.61% in June 2026. The stock trades at a PE of 82.90 against an industry PE of 37.33.
Ajanta Pharma: Return on Equity of 23.33%
Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.
The stock trades at a PE of 38.37 against an industry PE of 36.35, with a return on equity of 23.33%. In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026.
Low Debt and Fast Revenue Growth Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these low debt and fast revenue growth stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Coforge | 16,475.90 | 1,674.50 | 34.63% | 26.26% | 23.72% | 18.63% |
| Apar Industries | 22,966.89 | 976.93 | 22.95% | 25.19% | 39.67% | 12.05% |
| Sona BLW | 4,572.11 | 629.19 | 24.19% | 20.75% | 14.86% | 25.23% |
| Ajanta Pharma | 5,624.93 | 1,056 | 18.60% | 12.94% | 10.33% | 30.41% |
Check the Univest Screener for live data on these low debt and fast revenue growth stocks
Institutional Holding in Coforge, Apar Industries, Sona BLW and Ajanta Pharma
Institutional holding shows who is backing these low debt and fast revenue growth stocks alongside the promoter. The table uses the latest reported quarter for each. Coforge has the deepest institutional backing, with FII and DII together holding 66.93% as of June 2026. Domestic institutions increased their holding over the past year in Apar Industries (from 22.64% to 24.88%), Sona BLW (from 34.59% to 41.61%) and Ajanta Pharma (from 17.90% to 21.94%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Coforge | Nil | 24.31% | 42.62% | 33.07% | June 2026 |
| Apar Industries | 55.42% | 11.36% | 24.88% | 8.34% | August 2026 |
| Sona BLW | 28.01% | 23.61% | 41.61% | 6.77% | June 2026 |
| Ajanta Pharma | 63.47% | 7.63% | 21.94% | 6.96% | September 2026 |
Risks to Weigh in Low Debt and Fast Revenue Growth Stocks
Being careful with low debt and fast revenue growth stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Coforge trades at a PE of 46.24 against an industry PE of 17.66, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Low Debt and Fast Revenue Growth Stocks
Picking from low debt and fast revenue growth stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (17.66 to 46.39) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Coforge, Apar Industries, Sona BLW and Ajanta Pharma live prices.
Conclusion
Among low debt and fast revenue growth stocks, Coforge stands out for the largest market cap at Rs 88,801 crore, Apar Industries for the fastest profit growth, 39.67% a year since FY22, Sona BLW for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.07 and Ajanta Pharma for the highest return on equity at 23.33%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing low debt and fast revenue growth stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Low Debt and Fast Revenue Growth Stocks to Watch
Which are the best low debt and fast revenue growth stocks to watch for multibagger potential?
Ans. Coforge, Apar Industries, Sona BLW and Ajanta Pharma are the 4 names this list highlights, with market caps of Rs 88,801 crore, Rs 80,856 crore, Rs 56,870 crore and Rs 43,549 crore respectively. Coforge is notable for the largest market cap at Rs 88,801 crore. Apar Industries stands out for the fastest profit growth, 39.67% a year since FY22. Sona BLW offers a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.07. Ajanta Pharma brings the highest return on equity at 23.33%. These are watchlist names for low debt and fast revenue growth stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Ajanta Pharma a good stock for long-term investors?
Ans. Ajanta Pharma has a return on equity of 23.33%, a PE of 38.37 against an industry PE of 36.35 and a market cap of Rs 43,549 crore. Net profit has compounded at 10.33% a year since FY22, and FY26 revenue rose 18.60% while June 2026 quarter net profit grew 30.89%. Long-term returns in low debt and fast revenue growth stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Apar Industries become a multibagger from here?
Ans. Apar Industries has already gained 2287.98% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in low debt and fast revenue growth stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 39.67% a year since FY22, and FY26 revenue rose 22.95%. At a PE of 68.43 against an industry PE of 46.39, valuation should be checked against that growth before investing.
What is the market cap of Coforge, Apar Industries, Sona BLW and Ajanta Pharma?
Ans. As of 29 October 2026, Coforge has a market cap of Rs 88,801 crore, Apar Industries has a market cap of Rs 80,856 crore, Sona BLW has a market cap of Rs 56,870 crore and Ajanta Pharma has a market cap of Rs 43,549 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on low debt and fast revenue growth stocks.
What are the risks of investing in low debt and fast revenue growth stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Coforge trades at a PE of 46.24 against an industry PE of 17.66, so earnings growth needs to hold up.
Why is Coforge trading at a PE of 46.24?
Ans. Coforge’s PE of 46.24 compares with an industry PE of 17.66. The market is paying a premium for a return on equity of 16.31%, profit growth of 23.72% a year since FY22 and latest-quarter profit growth of 49.19%, which also means the stock is more sensitive if growth slows. Investors in low debt and fast revenue growth stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Coforge, Apar Industries, Sona BLW and Ajanta Pharma?
Ans. As of the latest reported quarter, FII and DII together hold 66.93% of Coforge (24.31% and 42.62%), 36.24% of Apar Industries (11.36% and 24.88%), 65.22% of Sona BLW (23.61% and 41.61%) and 29.57% of Ajanta Pharma (7.63% and 21.94%). Rising institutional holding is a useful signal in low debt and fast revenue growth stocks, though it should be read with earnings trends rather than on its own.
